CYTOKINETICS INC — Director's Dealing 2021

May 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-05-12

Reporting Person: Wysenski Nancy (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-12	Common Stock	A	5000	$0.0	Acquired	5459	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-12	Non-Qualified Stock Option (right to buy)	$24.32	A	10000	Acquired	2031-05-12	Common Stock (10000)	Direct

Footnotes

F1: Comprised of restricted stock units that will vest in full and in one installment on 05/12/2022.

F2: Amount includes 459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.

F3: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/12/2021 and the last such installment vesting on 05/12/2022.